The Effects of Eplerenone on Markers of Myocardial Fibrosis in Adult Congenital Heart Disease

NCT01971593 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

26

Enrollment

OTHER

Sponsor class

Stopped Investigator left institution

Conditions

Tetralogy of Fallot
Transposition of the Great Vessels With an Arterial Switch
Single Ventricle With a Fontan Palliation

Interventions

DRUG: Eplerenone

Sponsor

Washington University School of Medicine

Collaborators

[object Object]